Guidelines: Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer (Germany): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 25: | Line 25: | ||
<span style="display:none">availableVariable::tumour staging|stages</span> | <span style="display:none">availableVariable::tumour staging|stages</span> | ||
<span style="display:none">availableVariable::palliative care</span> | <span style="display:none">availableVariable::palliative care</span> | ||
<span style="display:none">isPracticeGuideline</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | <span style="display:none">hasCancerType::C50: Breast cancer</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none"> | <span style="display:none">Axilla</span> | ||
<span style="display:none">Axillary</span> | |||
<span style="display:none"> | <span style="display:none">Mammary</span> | ||
<span style="display:none"> | |||
Latest revision as of 12:03, 14 December 2025
Go back to Germany page
Primary purpose: To provide evidence-based recommendations for the interdisciplinary screening, diagnosis, therapy, and follow-up of breast cancer, aimed at optimizing patient care.
Sponsor, manager or home institution: German Society for Gynecology and Obstetrics (DGGG) and German Cancer Society (DKG).
Type of information: Recommendations for the screening, diagnosis, therapy, and follow-up care of breast cancer. It includes methods such as mammography and ultrasound for early detection, as well as imaging and biopsy procedures for diagnosis. Therapeutic recommendations cover surgery, chemotherapy, and radiotherapy tailored to various stages of breast cancer. The guideline also outlines follow-up care protocols to monitor recurrence and manage long-term side effects, along with guidelines for genetic testing in cases of hereditary breast cancer. Additionally, it addresses rehabilitation and palliative care to support patients throughout their treatment journey Click here to learn more.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
